{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:45:47Z","timestamp":1789152347679,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82072832"],"award-info":[{"award-number":["82072832"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu Province Hospital (the First Affiliated Hospital of Nanjing Medical University) Clinical Capacity Enhancement Project","award":["JSPH-MA-2022-5"],"award-info":[{"award-number":["JSPH-MA-2022-5"]}]},{"name":"Jiangsu Province Capability Improvement Project through Science, Technology and Education","award":["ZDXK202219"],"award-info":[{"award-number":["ZDXK202219"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vesical Imaging-Reporting and Data System (VI-RADS) based on multiparametric MRI (mp-MRI) demonstrated excellent performance in diagnosing muscle-invasive bladder cancer (MIBC) in cases of pure urothelial carcinoma. However, the performance of VI-RADS based on mp-MRI and biparametric MRI (bp-MRI) in diagnosing urothelial carcinoma with variant histology (VUC) remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To evaluate the applicability of VI-RADS using mp-MRI and bp-MRI in diagnosing MIBC in patients with VUC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted on 86 patients with VUC from different medical centers. Each patient underwent mp-MRI, with images evaluated using VI-RADS scores. The acquired images were divided into two groups: the mp-MRI group and the bp-MRI group. The mp-MRI group was evaluated according to the VI-RADS protocol. For the bp-MRI group, two VI-RADS scoring criteria were established: bp-DWI, primarily driven by DWI, and bp-T2WI, primarily driven by T2WI. The bp-MRI group was evaluated based on these two criteria. Inter-reader agreement performance was evaluated using Kappa analysis. The evaluation methods were evaluated by receiver operating characteristic curve. Comparison of the area under the curve (AUC) was performed used DeLong\u2019s test. A p-value\u2009&lt;\u20090.05 was considered significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Inter-reader agreement was high across all evaluation methods, with Kappa values exceeding 0.80. The AUCs for mp-MRI, bp-DWI, and bp-T2WI were 0.934, 0.885, and 0.932, respectively. The diagnostic performance of bp-T2WI was comparable with that of mp-MRI (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.682) and significantly higher than bp-DWI (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007). Both mp-MRI and bp-T2WI demonstrated high sensitivity and specificity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>VI-RADS based on mp-MRI demonstrates good diagnostic performance for MIBC in VUC patients. bp-T2WI may provide comparable diagnostic performance to mp-MRI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40644-025-00831-x","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T05:57:51Z","timestamp":1739858271000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluating biparametric MRI for diagnosing muscle-invasive bladder cancer with variant urothelial histology: a multicenter study"],"prefix":"10.1186","volume":"25","author":[{"given":"Peikun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingkai","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Que","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongcheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"issue":"1","key":"831_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, et al. European Association of Urology Guidelines on non-muscle-invasive bladder Cancer (Ta, T1, and carcinoma in situ). Eur Urol. 2022;81(1):75\u201394.","journal-title":"Eur Urol"},{"issue":"1","key":"831_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.urology.2007.03.033","volume":"70","author":"MJ Wasco","year":"2007","unstructured":"Wasco MJ, et al. Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection. Urology. 2007;70(1):69\u201374.","journal-title":"Urology"},{"issue":"5","key":"831_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.5858\/arpa.2017-0539-RA","volume":"143","author":"G Wang","year":"2019","unstructured":"Wang G, McKenney JK. Urinary bladder Pathology: World Health Organization Classification and American Joint Committee on Cancer staging update. Arch Pathol Lab Med. 2019;143(5):571\u20137.","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"831_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes JA, et al. European Association of Urology Guidelines on muscle-invasive and metastatic bladder Cancer: Summary of the 2020 guidelines. Eur Urol. 2021;79(1):82\u2013104.","journal-title":"Eur Urol"},{"issue":"5","key":"831_CR5","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.urology.2014.06.032","volume":"84","author":"T Cai","year":"2014","unstructured":"Cai T, et al. Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens. Urology. 2014;84(5):1141\u20136.","journal-title":"Urology"},{"issue":"6","key":"831_CR6","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1097\/JU.0000000000001305","volume":"204","author":"K Mori","year":"2020","unstructured":"Mori K, et al. A systematic review and Meta-analysis of variant histology in Urothelial Carcinoma of the bladder treated with Radical Cystectomy. J Urol. 2020;204(6):1129\u201340.","journal-title":"J Urol"},{"issue":"4","key":"831_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.euf.2019.09.003","volume":"6","author":"N Lobo","year":"2020","unstructured":"Lobo N, et al. What is the significance of variant histology in Urothelial Carcinoma? Eur Urol Focus. 2020;6(4):653\u201363.","journal-title":"Eur Urol Focus"},{"issue":"6","key":"831_CR8","doi-asserted-by":"publisher","first-page":"650","DOI":"10.23736\/S0393-2249.20.04018-7","volume":"72","author":"E Polo-Alonso","year":"2020","unstructured":"Polo-Alonso E, et al. Trimodal therapy in muscle invasive bladder cancer management. Minerva Urol Nefrol. 2020;72(6):650\u201362.","journal-title":"Minerva Urol Nefrol"},{"issue":"4","key":"831_CR9","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1097\/JU.0000000000001886","volume":"206","author":"A Martini","year":"2021","unstructured":"Martini A, et al. Oncologic surveillance for variant histology bladder Cancer after Radical Cystectomy. J Urol. 2021;206(4):885\u201393.","journal-title":"J Urol"},{"issue":"1","key":"831_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.euf.2023.07.002","volume":"10","author":"T Yanagisawa","year":"2024","unstructured":"Yanagisawa T, et al. Repeat Transurethral Resection for non-muscle-invasive bladder Cancer: an updated systematic review and Meta-analysis in the contemporary era. Eur Urol Focus. 2024;10(1):41\u201356.","journal-title":"Eur Urol Focus"},{"issue":"3","key":"831_CR11","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","volume":"74","author":"V Panebianco","year":"2018","unstructured":"Panebianco V, et al. Multiparametric magnetic resonance imaging for bladder Cancer: development of VI-RADS (Vesical Imaging-Reporting and Data System). Eur Urol. 2018;74(3):294\u2013306.","journal-title":"Eur Urol"},{"issue":"1","key":"831_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.eururo.2019.03.012","volume":"76","author":"Y Ueno","year":"2019","unstructured":"Ueno Y, et al. Diagnostic accuracy and interobserver agreement for the Vesical Imaging-Reporting and Data System for muscle-invasive bladder Cancer: a Multireader Validation Study. Eur Urol. 2019;76(1):54\u20136.","journal-title":"Eur Urol"},{"issue":"3","key":"831_CR13","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.euo.2020.02.007","volume":"3","author":"S Woo","year":"2020","unstructured":"Woo S, et al. Diagnostic performance of Vesical Imaging Reporting and Data System for the prediction of muscle-invasive bladder Cancer: a systematic review and Meta-analysis. Eur Urol Oncol. 2020;3(3):306\u201315.","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"831_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.euo.2022.07.006","volume":"6","author":"Y Arita","year":"2023","unstructured":"Arita Y, et al. Diagnostic value of the Vesical Imaging-Reporting and Data System in bladder urothelial carcinoma with variant histology. Eur Urol Oncol. 2023;6(1):99\u2013102.","journal-title":"Eur Urol Oncol"},{"issue":"11","key":"831_CR15","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.ejrad.2014.08.012","volume":"83","author":"G Zhou","year":"2014","unstructured":"Zhou G, et al. Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer. Eur J Radiol. 2014;83(11):2013\u20138.","journal-title":"Eur J Radiol"},{"issue":"4","key":"831_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.prnil.2019.12.004","volume":"8","author":"J Cho","year":"2020","unstructured":"Cho J, et al. Biparametric versus multiparametric magnetic resonance imaging of the prostate: detection of clinically significant cancer in a perfect match group. Prostate Int. 2020;8(4):146\u201351.","journal-title":"Prostate Int"},{"issue":"4","key":"831_CR17","doi-asserted-by":"publisher","first-page":"e070280","DOI":"10.1136\/bmjopen-2022-070280","volume":"13","author":"A Asif","year":"2023","unstructured":"Asif A, et al. Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol. BMJ Open. 2023;13(4):e070280.","journal-title":"BMJ Open"},{"issue":"9","key":"831_CR18","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.1007\/s00330-022-08696-5","volume":"32","author":"L Ye","year":"2022","unstructured":"Ye L, et al. Biparametric magnetic resonance imaging assessment for detection of muscle-invasive bladder cancer: a systematic review and meta-analysis. Eur Radiol. 2022;32(9):6480\u201392.","journal-title":"Eur Radiol"},{"issue":"1","key":"831_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.euf.2023.08.004","volume":"10","author":"Y Arita","year":"2024","unstructured":"Arita Y, et al. Biparametric versus Multiparametric Magnetic Resonance Imaging for Assessing Muscle Invasion in bladder urothelial carcinoma with variant histology using the Vesical Imaging-Reporting and Data System. Eur Urol Focus. 2024;10(1):131\u20138.","journal-title":"Eur Urol Focus"},{"issue":"8","key":"831_CR20","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.ejca.2013.02.001","volume":"49","author":"E Xylinas","year":"2013","unstructured":"Xylinas E, et al. Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. Eur J Cancer. 2013;49(8):1889\u201397.","journal-title":"Eur J Cancer"},{"issue":"1","key":"831_CR21","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1016\/j.urolonc.2014.10.013","volume":"33","author":"A Soave","year":"2015","unstructured":"Soave A, et al. Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy? Urol Oncol. 2015;33(1):e211\u20139.","journal-title":"Urol Oncol"},{"issue":"6","key":"831_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.urolonc.2016.12.006","volume":"35","author":"M Moschini","year":"2017","unstructured":"Moschini M, et al. Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy. Urol Oncol. 2017;35(6):335\u201341.","journal-title":"Urol Oncol"},{"issue":"11","key":"831_CR23","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrurol.2017.125","volume":"14","author":"M Moschini","year":"2017","unstructured":"Moschini M, et al. Characteristics and clinical significance of histological variants of bladder cancer. Nat Rev Urol. 2017;14(11):651\u201368.","journal-title":"Nat Rev Urol"},{"issue":"4","key":"831_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.eururo.2018.11.052","volume":"75","author":"M Abufaraj","year":"2019","unstructured":"Abufaraj M, et al. Micropapillary Urothelial Carcinoma of the bladder: a systematic review and Meta-analysis of Disease characteristics and treatment outcomes. Eur Urol. 2019;75(4):649\u201358.","journal-title":"Eur Urol"},{"issue":"3","key":"831_CR25","doi-asserted-by":"publisher","first-page":"e1081","DOI":"10.1016\/j.urolonc.2021.09.017","volume":"40","author":"S Woo","year":"2022","unstructured":"Woo S, et al. Plasmacytoid urothelial carcinoma of the bladder: MRI features and their association with survival. Urol Oncol. 2022;40(3):e1081\u201310810.","journal-title":"Urol Oncol"},{"issue":"6","key":"831_CR26","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1007\/s00330-020-07473-6","volume":"31","author":"PA Delli","year":"2021","unstructured":"Delli PA, et al. Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi-reader VI-RADS approach. Eur Radiol. 2021;31(6):3874\u201383.","journal-title":"Eur Radiol"},{"issue":"11","key":"831_CR27","doi-asserted-by":"publisher","first-page":"7513","DOI":"10.1007\/s00330-022-08813-4","volume":"32","author":"M Watanabe","year":"2022","unstructured":"Watanabe M, et al. Clinical validity of non-contrast-enhanced VI-RADS: prospective study using 3-T MRI with high-gradient magnetic field. Eur Radiol. 2022;32(11):7513\u201321.","journal-title":"Eur Radiol"},{"issue":"1","key":"831_CR28","doi-asserted-by":"publisher","first-page":"20689","DOI":"10.1038\/s41598-022-19273-7","volume":"12","author":"TI Noh","year":"2022","unstructured":"Noh TI, et al. Comparison between biparametric and multiparametric MRI in predicting muscle invasion by bladder cancer based on the VI-RADS. Sci Rep. 2022;12(1):20689.","journal-title":"Sci Rep"},{"issue":"2","key":"831_CR29","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00261-021-03383-3","volume":"47","author":"S Aslan","year":"2022","unstructured":"Aslan S, et al. Comparison of the diagnostic accuracy and validity of biparametric MRI and multiparametric MRI-based VI-RADS scoring in bladder cancer; is contrast material really necessary in detecting muscle invasion? Abdom Radiol (NY). 2022;47(2):771\u201380.","journal-title":"Abdom Radiol (NY)"},{"issue":"8","key":"831_CR30","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.acra.2013.02.012","volume":"20","author":"LM Wu","year":"2013","unstructured":"Wu LM, et al. Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI. Acad Radiol. 2013;20(8):939\u201346.","journal-title":"Acad Radiol"},{"issue":"5","key":"831_CR31","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.juro.2008.07.035","volume":"180","author":"HM Fritsche","year":"2008","unstructured":"Fritsche HM, et al. Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases. J Urol. 2008;180(5):1923\u20137.","journal-title":"J Urol"},{"issue":"2","key":"831_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/JU.0000000000000794","volume":"204","author":"DK Kim","year":"2020","unstructured":"Kim DK, et al. Plasmacytoid variant Urothelial Carcinoma of the bladder: a systematic review and Meta-analysis of Clinicopathological features and survival outcomes. J Urol. 2020;204(2):215\u201323.","journal-title":"J Urol"},{"key":"831_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2024.04.012","volume":"148","author":"L Zheng","year":"2024","unstructured":"Zheng L, et al. Plasmacytoid urothelial carcinoma of the urinary bladder-A clinicopathological and molecular analysis of 52 cases. Hum Pathol. 2024;148:1\u20136.","journal-title":"Hum Pathol"},{"issue":"1\u20132","key":"831_CR34","doi-asserted-by":"publisher","first-page":"E50","DOI":"10.5489\/cuaj.3789","volume":"11","author":"AD Chung","year":"2017","unstructured":"Chung AD, et al. Plasmacytoid urothelial carcinoma (PUC): imaging features with histopathological correlation. Can Urol Assoc J. 2017;11(1\u20132):E50\u20137.","journal-title":"Can Urol Assoc J"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-025-00831-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-025-00831-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-025-00831-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T05:57:56Z","timestamp":1739858276000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-025-00831-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["831"],"URL":"https:\/\/doi.org\/10.1186\/s40644-025-00831-x","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Given the retrospective design of this study, the requirement for ethical approval was waived by the institutional review board. Written informed consent was obtained from patients for the use of their relevant information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from patients for the use of their relevant information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}